temazepam has been researched along with Chronic Insomnia in 90 studies
Temazepam: A benzodiazepine that acts as a GAMMA-AMINOBUTYRIC ACID modulator and anti-anxiety agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study reports on the incidence of adverse effects of temazepam in older adults with chronic insomnia and examines whether the addition of cognitive-behaviour therapy (CBT) is associated with less drug used and fewer adverse effects." | 9.10 | Adverse effects of temazepam in older adults with chronic insomnia. ( Bastien, CH; Brink, D; Brown, TR; Morin, CM, 2003) |
| "This randomised controlled trial was conducted to compare zolpidem to an equivalent dose of temazepam with respect to subjective rebound insomnia after cessation of 4 weeks of treatment in chronic insomnia (zolpidem 10 mg, n=79; temazepam 20 mg, n=84)." | 5.11 | Zolpidem is not superior to temazepam with respect to rebound insomnia: a controlled study. ( van Balkom, AJ; Voshaar, RC; Zitman, FG, 2004) |
| "This study reports on the incidence of adverse effects of temazepam in older adults with chronic insomnia and examines whether the addition of cognitive-behaviour therapy (CBT) is associated with less drug used and fewer adverse effects." | 5.10 | Adverse effects of temazepam in older adults with chronic insomnia. ( Bastien, CH; Brink, D; Brown, TR; Morin, CM, 2003) |
| " Only few controlled studies have characterized the effect of discontinuation of their chronic use on sleep and quality of life." | 2.90 | Withdrawal from long-term use of zopiclone, zolpidem and temazepam may improve perceived sleep and quality of life in older adults with primary insomnia. ( Kivelä, SL; Lähteenmäki, R; Neuvonen, PJ; Partinen, M; Puustinen, J; Räihä, I; Vahlberg, T, 2019) |
| "92 outpatients (≥55 years) with primary insomnia, long-term BZDA use as hypnotics (mean duration of BZDA use 9." | 2.87 | Long-term persistence of withdrawal of temazepam, zopiclone, and zolpidem in older adults: a 3-year follow-up study. ( Aarnio, P; Kivelä, SL; Lähteenmäki, R; Neuvonen, PJ; Nurminen, J; Partinen, M; Puustinen, J; Räihä, I; Vahlberg, T, 2018) |
| "Withdrawal from long-term use of benzodiazepines can rapidly improve muscle strength and balance." | 2.79 | Handgrip strength and balance in older adults following withdrawal from long-term use of temazepam, zopiclone or zolpidem as hypnotics. ( Kivelä, SL; Lähteenmäki, R; Lyles, A; Neuvonen, PJ; Nurminen, J; Partinen, M; Puustinen, J; Räihä, I; Vahlberg, T, 2014) |
| "Thirty-eight insomniacs took part in a 5-week, double-blind, placebo-controlled study of the effects of 2 weeks of administration of temazepam 20 mg on sleep." | 2.71 | Evaluation of actigraphy and automated telephoned questionnaires to assess hypnotic effects in insomnia. ( Nutt, DJ; Potokar, J; Rich, AS; Rich, NC; Wilson, SJ, 2004) |
| "Occasionally, insomniac patients may take a sleeping pill after midnight." | 2.71 | Effects of after-midnight intake of zolpidem and temazepam on driving ability in women with non-organic insomnia. ( Halavaara, M; Hiltunen, H; Hirvonen, K; Hublin, C; Partinen, M, 2003) |
| "Temazepam was well tolerated, and no significant differences between doses were found for adverse event (AE) incidence, mean score on the Digit Symbol Substitution Task, or mean scores on questions related to tolerability from the Leeds Sleep Evaluation Questionnaire." | 2.71 | Comparison of temazepam 7.5 mg with temazepam 15 mg for the treatment of transient insomnia. ( Erman, MK; Loewy, D; Scharf, MB, 2004) |
| "Hypnograms from 21 patients with primary insomnia were collected during a randomized, placebo-controlled crossover study of 20 mg temazepam." | 2.69 | A pharmacodynamic Markov mixed-effects model for the effect of temazepam on sleep. ( Cohen, AF; Danhof, M; Karlsson, MO; Kemp, B; Peck, CC; Schoemaker, RC; Tuk, B; van Gerven, JM, 2000) |
| "Insomnia is a prevalent health complaint in older adults." | 2.69 | Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. ( Brink, D; Colecchi, C; Morin, CM; Sood, R; Stone, J, 1999) |
| "A transient insomnia model, the "first night" effect in the sleep laboratory, was used to assess the dose range for the hypnotic and sleep stage effects of temazepam." | 2.67 | Dose effects of temazepam in transient insomnia. ( Roehrs, T; Roth, T; Sterling, W; Vogel, G, 1990) |
| "Zopiclone is an effective hypnotic comparable to temazepam." | 2.67 | A double-blind placebo-controlled trial of zopiclone 7.5 mg and temazepam 20 mg in insomnia. ( Hassan, R; Ngen, CC, 1990) |
| "With temazepam this effect was more variable, with total wake time increased only with the second withdrawal period (39%)." | 2.67 | Rebound insomnia after only brief and intermittent use of rapidly eliminated benzodiazepines. ( Bixler, EO; Fee, EC; Kales, A; Manfredi, RL; Vela-Bueno, A; Vgontzas, AN, 1991) |
| "Temazepam was consistently less potent than chlormethiazole on tests of drowsiness and psychomotor performance." | 2.67 | A single-dose study of the pharmacodynamic effects of chlormethiazole, temazepam and placebo in elderly parkinsonian patients. ( Ashwood, TJ; Bateman, DN; Tulloch, JA; Woodhouse, KW, 1991) |
| "There was no rebound insomnia when temazepam was withdrawn either abruptly or gradually in long-term hospitalised elderly patients and may not be effective as a long-term hypnotic." | 2.66 | Temazepam withdrawal in elderly hospitalized patients: a double blind randomised trial comparing abrupt versus gradual withdrawal. ( Brown, H; Taggart, HM; Tham, TC, 1989) |
| "Temazepam did not produce any behavioral side effects during either drug condition." | 2.66 | Quazepam and temazepam: effects of short- and intermediate-term use and withdrawal. ( Bixler, EO; Jacoby, JA; Kales, A; Kales, JD; Soldatos, CR; Vela-Bueno, A, 1986) |
| "With chlormethiazole treatment there was no daytime drowsiness, whereas significant daytime drowsiness occurred with temazepam." | 2.66 | A double-blind comparison of chlormethiazole and temazepam in elderly patients with sleep disturbances. ( Bayer, AJ; Pathy, MS; Stoker, MJ, 1986) |
| " Dosing lasted 7 days." | 2.66 | Saccadic eye movements as a measure of residual effects: temazepam compared with other hypnotics. ( Hofferberth, B, 1986) |
| "Zopiclone was associated with feelings of being troubled, tense, antagonistic and bored whereas temazepam produced drowsiness, clumsiness, dreaminess and sadness." | 2.66 | Subjective effects during administration and on discontinuation of zopiclone and temazepam in normal subjects. ( Frcka, G; Lader, M, 1987) |
| "Midazolam (15 mg) was compared with temazepam (30 mg) in a randomized, double-blind, parallel group study." | 2.66 | Efficacy without tolerance or rebound insomnia for midazolam and temazepam after use for one to three months. ( Allen, RP; Chernik, DA; Hoddes, E; Mendels, J; Nevins, DB, 1987) |
| "In it, 12 female formerly diagnosed insomniacs and hypnotic users acted as subjects." | 2.66 | Hypnotics and actual driving performance. ( O'Hanlon, JF; Volkerts, ER, 1986) |
| "The aetiology of insomnia can be conveniently divided into six groups: physical (pain, cough, etc." | 2.66 | Insomnia in general practice: the role of temazepam and a comparison with zopiclone. ( Wheatley, D, 1986) |
| "Sixty Filipino insomniacs participated in a double-blind study of temazepam on an outpatient basis." | 2.65 | Treatment of insomnia with temazepam: double-blind, placebo-controlled evaluation. ( Cuanang, JR; Limos, L, 1982) |
| "Experimental sleep disturbances (model insomnia) were produced by the administration of methylphenidate (MPD) 10 mg and caffeine (CAF) 150 mg." | 2.65 | Model insomnia by methylphenidate and caffeine and use in the evaluation of temazepam. ( Matsue, Y; Matsuoka, H; Okuma, T; Toyomura, K, 1982) |
| "Fifty-five patients complaining of insomnia entered a single-blind general practice study and were treated with either 400 mg chlormezanone or 20 mg temazepam at night for 2 weeks." | 2.65 | A comparison of chlormezanone and temazepam in sleep disturbance. ( Van Steenis, D, 1982) |
| "Seventy insomniac patients, previously unresponsive to conventional hypnotic dosage, were treated for seven nights with temazepam in 20 mg soft gelatin capsules (Euhypnos Forte)." | 2.65 | Euhypnos Forte (temazepam) for resistant insomnia: a clinical trial. ( Moon, CA; Schiller, M, 1979) |
| "1 Temazepam was evaluated in a strictly defined insomniac patient population under sleep laboratory conditions." | 2.65 | Hypnotic efficacy of temazepam: a long-term sleep laboratory evaluation. ( Carskadon, MA; Dement, WC; Guilleminault, C; Mitler, MM; Phillips, RL; Spiegel, R; Sterling, WR; Zarcone, VP, 1979) |
| " Other agents commonly used at sea-level such as eszopiclone and diphenhydramine have not been studied at high altitude but are likely safe to use given their mechanism of action and known side effects." | 2.44 | Which medications are safe and effective for improving sleep at high altitude? ( Luks, AM, 2008) |
| "Up to 40% of adults have insomnia, with difficulty getting to sleep, early waking, or feeling unrefreshed on waking." | 2.44 | Insomnia in the elderly. ( Lilly, J; Montgomery, P, 2007) |
| "Patients with insomnia are characterised by excessive arousal and an inability to sleep despite reported reduced sleep hours and poor sleep quality." | 2.41 | Insomnia. Diagnosis and management. ( Grunstein, R, 2002) |
| "The risk of rebound insomnia is greater with the short half-life as compared with the long half-life benzodiazepines." | 2.38 | Rebound insomnia: a critical review. ( Gillin, JC; Johnson, LC; Spinweber, CL, 1989) |
| "Consequently, while the majority of insomniac patients complain primarily of difficulty falling asleep, temazepam is not effective for this sleep complaint." | 2.36 | Sleep laboratory studies of hypnotic drugs: efficacy and withdrawal effects. ( Kales, A; Kales, JD, 1983) |
| "Ninety-two adults (age ≥55 years) with primary insomnia and who were long-term daily users of BZD volunteered to participate in a 1-month medically supported withdrawal attempt from BZD use, with a subsequent 5-month follow-up." | 1.40 | Effect of withdrawal from long-term use of temazepam, zopiclone or zolpidem as hypnotic agents on cognition in older adults. ( Kivelä, SL; Lähteenmäki, R; Lyles, A; Neuvonen, PJ; Partinen, M; Polo-Kantola, P; Puustinen, J; Räihä, I; Salo, P; Vahlberg, T, 2014) |
| "Transient insomnia was induced in the sleep laboratory by means of the 'first night' effect and by implementing a 2-h phase advance." | 1.33 | Effects of temazepam 7.5 mg and temazepam 15 mg on sleep maintenance and sleep architecture in a model of transient insomnia. ( Erman, MK; Loewy, DB; Scharf, MB, 2005) |
| "(1) In chronic insomnia, cognitive-behaviour treatments appear to be as effective as benzodiazepines." | 1.31 | Behaviour therapy for chronic insomnia. ( , 2001) |
| "All were within 1-3 weeks of trauma exposure and had acute PTSD symptoms that included disturbed sleep." | 1.30 | Pilot evaluation of hypnotic medication during acute traumatic stress response. ( Augenstein, JS; Byers, PM; Mellman, TA, 1998) |
| "The correlation between the pharmacodynamic measures and sleep quality was determined in 21 patients with primary insomnia." | 1.30 | Pharmacodynamics of temazepam in primary insomnia: assessment of the value of quantitative electroencephalography and saccadic eye movements in predicting improvement of sleep. ( Breimer, DD; Cohen, AF; Danhof, M; Kamphuisen, HA; Kemp, B; Oberyé, JJ; Peck, CC; Pieters, MS; Schoemaker, RC; Tuk, B; van Gerven, J, 1997) |
| "Temazepam, 7." | 1.29 | Temazepam 7.5 mg: effects on sleep in elderly insomniacs. ( Bixler, EO; Kales, A; Myers, DC; Vgontzas, AN, 1994) |
| "Rates of insomnia visits are somewhat higher for middle-aged (45 to 64 years of age) women, and data for female insomniacs suggest a trend toward diagnoses of depression compared with other (somatic) diagnoses for men." | 1.29 | Management of insomnia in office-based practice. National prevalence and therapeutic patterns. ( Brunton, SA; Radecki, SE, 1993) |
| "An untreated insomnia group also was included." | 1.28 | The beneficial and adverse effects of hypnotics. ( Balter, MB; Uhlenhuth, EH, 1991) |
| "Two noncontinuous sleep disturbances, insomnia in the elderly and transient insomnia in young and middle-aged adults, are probably the most acceptable indications for the use of benzodiazepines." | 1.28 | Clinical uses and advantages of low doses of benzodiazepine hypnotics. ( Vogel, G, 1992) |
| "Side effects involving agitation, e." | 1.27 | Agitation observed during treatment with newer hypnotic drugs. ( Regestein, QR; Reich, P, 1985) |
| "When the various benzodiazepine hypnotics are studied, large differences are seen with regard to their pharmacokinetic properties and metabolism in man." | 1.27 | Pharmacokinetics of temazepam compared with other benzodiazepine hypnotics--some clinical consequences. ( Breimer, DD; Jochemsen, R, 1986) |
| "The relationship of insomnia with the hypoxic environment is undetermined." | 1.27 | Hypnotics and transient insomnia. ( Nicholson, AN; Stone, BM, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 52 (57.78) | 18.7374 |
| 1990's | 16 (17.78) | 18.2507 |
| 2000's | 18 (20.00) | 29.6817 |
| 2010's | 4 (4.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Puustinen, J | 4 |
| Lähteenmäki, R | 4 |
| Nurminen, J | 2 |
| Vahlberg, T | 4 |
| Aarnio, P | 1 |
| Partinen, M | 5 |
| Räihä, I | 4 |
| Neuvonen, PJ | 4 |
| Kivelä, SL | 4 |
| Polo-Kantola, P | 1 |
| Salo, P | 1 |
| Lyles, A | 2 |
| Luks, AM | 1 |
| Montgomery, P | 1 |
| Lilly, J | 1 |
| Hislop, J | 1 |
| Arber, S | 1 |
| Grunstein, R | 1 |
| Morin, CM | 3 |
| Bastien, CH | 1 |
| Brink, D | 2 |
| Brown, TR | 1 |
| Hirvonen, K | 1 |
| Hublin, C | 1 |
| Halavaara, M | 1 |
| Hiltunen, H | 1 |
| Wilson, SJ | 1 |
| Rich, AS | 1 |
| Rich, NC | 1 |
| Potokar, J | 1 |
| Nutt, DJ | 1 |
| Erman, MK | 2 |
| Loewy, D | 1 |
| Scharf, MB | 3 |
| Voshaar, RC | 1 |
| van Balkom, AJ | 1 |
| Zitman, FG | 1 |
| Romasenko, LV | 1 |
| Parkhomenko, IM | 1 |
| Loewy, DB | 1 |
| Iraqi, A | 1 |
| Hughes, TL | 1 |
| Glass, JR | 1 |
| Sproule, BA | 1 |
| Herrmann, N | 1 |
| Busto, UE | 1 |
| Fowler, LK | 2 |
| Schiller, M | 2 |
| Linnoila, M | 1 |
| Viukari, M | 1 |
| Lamminsivu, U | 1 |
| Auvinen, J | 1 |
| Fillingim, JM | 2 |
| Cuanang, JR | 1 |
| Limos, L | 1 |
| Okuma, T | 2 |
| Matsuoka, H | 1 |
| Matsue, Y | 1 |
| Toyomura, K | 1 |
| Van Steenis, D | 1 |
| Laffont, F | 1 |
| Cathala, HP | 1 |
| Esnault, S | 1 |
| Gilbert, A | 1 |
| Minz, M | 1 |
| Peytourg, MA | 1 |
| Waisbord, P | 1 |
| Rickels, K | 1 |
| Kales, A | 5 |
| Kales, JD | 3 |
| Saletu, B | 1 |
| Grünberger, J | 1 |
| Anderer, P | 1 |
| Conell, LJ | 1 |
| Berlin, RM | 1 |
| Gringras, M | 1 |
| Beaumont, G | 1 |
| Ankier, SI | 1 |
| Beary, MD | 1 |
| Lacey, JH | 1 |
| Crutchfield, MB | 1 |
| Bhat, AV | 1 |
| Roehrs, T | 4 |
| Lamphere, J | 2 |
| Paxton, C | 2 |
| Wittig, R | 2 |
| Zorick, F | 3 |
| Roth, T | 5 |
| de Jonghe, F | 1 |
| Ameling, EH | 1 |
| Jonkers, F | 1 |
| Folkers, C | 1 |
| Schwarz, RV | 1 |
| Wesnes, K | 1 |
| Warburton, DM | 1 |
| Lader, MH | 1 |
| Hiraga, H | 1 |
| Ichijo, S | 1 |
| Vgontzas, AN | 3 |
| Bixler, EO | 4 |
| Myers, DC | 1 |
| Radecki, SE | 1 |
| Brunton, SA | 1 |
| Griffith, DN | 1 |
| Robinson, M | 1 |
| Tuk, B | 2 |
| Oberyé, JJ | 1 |
| Pieters, MS | 1 |
| Schoemaker, RC | 2 |
| Kemp, B | 2 |
| van Gerven, J | 1 |
| Danhof, M | 2 |
| Kamphuisen, HA | 1 |
| Cohen, AF | 2 |
| Breimer, DD | 2 |
| Peck, CC | 2 |
| Mellman, TA | 1 |
| Byers, PM | 1 |
| Augenstein, JS | 1 |
| Colecchi, C | 1 |
| Stone, J | 1 |
| Sood, R | 1 |
| Karlsson, MO | 1 |
| van Gerven, JM | 1 |
| Arnedt, JT | 1 |
| Martin, JL | 1 |
| Posner, DA | 1 |
| Ramesh, M | 1 |
| Roberts, G | 1 |
| Blais, F | 1 |
| Savard, J | 1 |
| Sussman, HS | 1 |
| Moon, CA | 1 |
| Mitler, MM | 2 |
| Carskadon, MA | 1 |
| Phillips, RL | 1 |
| Sterling, WR | 1 |
| Zarcone, VP | 1 |
| Spiegel, R | 1 |
| Guilleminault, C | 1 |
| Dement, WC | 1 |
| Heffron, WA | 1 |
| Roth, P | 1 |
| Nicholson, AN | 3 |
| Nakra, BR | 1 |
| Gfeller, JD | 1 |
| Hassan, R | 2 |
| Vogel, G | 3 |
| Manfredi, RL | 2 |
| Tyson, KL | 1 |
| Walsh, JK | 1 |
| Mahowald, MW | 1 |
| Roehrs, TA | 1 |
| Tulloch, JA | 1 |
| Ashwood, TJ | 1 |
| Bateman, DN | 1 |
| Woodhouse, KW | 1 |
| Vela-Bueno, A | 2 |
| Fee, EC | 1 |
| Balter, MB | 1 |
| Uhlenhuth, EH | 1 |
| Ngen, CC | 1 |
| Sterling, W | 1 |
| Gillin, JC | 1 |
| Spinweber, CL | 1 |
| Johnson, LC | 1 |
| Tham, TC | 1 |
| Brown, H | 1 |
| Taggart, HM | 1 |
| Sussman, N | 1 |
| Wheatley, D | 2 |
| Hauri, P | 1 |
| Sateia, M | 1 |
| Kipp, J | 1 |
| Regestein, QR | 1 |
| Reich, P | 1 |
| Soldatos, CR | 1 |
| Jacoby, JA | 1 |
| Allen, RM | 1 |
| Fancourt, G | 1 |
| Castleden, M | 1 |
| Pathy, MS | 1 |
| Bayer, AJ | 1 |
| Stoker, MJ | 1 |
| Vogel, F | 1 |
| Browman, CP | 1 |
| Menn, SJ | 1 |
| Gujavarty, K | 1 |
| Timms, RM | 1 |
| Hofferberth, B | 1 |
| Schmidt, U | 1 |
| Brendemühl, D | 1 |
| Rüther, E | 1 |
| Jochemsen, R | 1 |
| Hindmarch, I | 1 |
| Stone, BM | 2 |
| Lader, M | 1 |
| Frcka, G | 1 |
| Meuleman, JR | 1 |
| Nelson, RC | 1 |
| Clark, RL | 1 |
| Allen, RP | 1 |
| Mendels, J | 1 |
| Nevins, DB | 1 |
| Chernik, DA | 1 |
| Hoddes, E | 1 |
| Fletcher, K | 1 |
| Graham, JP | 1 |
| Smith, PA | 1 |
| Bradwell, AR | 1 |
| Coote, JH | 1 |
| DiBella, GA | 1 |
| O'Hanlon, JF | 1 |
| Volkerts, ER | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Development of a Coordinated, Community-Based Medication Management Model for Home-Dwelling Aged in Primary Care[NCT02545257] | 191 participants (Actual) | Interventional | 2015-09-30 | Completed | |||
| Addressing Nocturnal Sleep/Wake Effects on Risk of Suicide in Older Adults (ANSWERS-OA): A Pilot, Open-Label, Randomized Controlled Trial of Digital Cognitive Behavioral Therapy for Insomnia[NCT04986007] | 70 participants (Anticipated) | Interventional | 2021-09-01 | Enrolling by invitation | |||
| Treatment of High-altitude Sleep Disturbance: A Double-blind Comparison of Temazepam Versus Acetazolamide.[NCT01519544] | 34 participants (Actual) | Interventional | 2012-03-31 | Completed | |||
| Efficacy Potential of an Internet-based Sleep Program to Improve Sleep Quality in People With HIV[NCT02571595] | 27 participants (Actual) | Interventional | 2015-05-31 | Terminated | |||
| Randomized Controlled Trials to Evaluate Health enSuite Insomnia: an App Based Treatment for Adult Chronic Insomnia[NCT04962087] | 830 participants (Anticipated) | Interventional | 2022-06-29 | Not yet recruiting | |||
| Method of Assessment of Driving Ability in Patients Suffering From Wakefulness Pathologies, Impact of Modafinil Treatment.[NCT00916253] | 27 participants (Actual) | Interventional | 2010-03-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 reviews available for temazepam and Chronic Insomnia
| Article | Year |
|---|---|
Which medications are safe and effective for improving sleep at high altitude?
Topics: Acetamides; Acetazolamide; Altitude Sickness; Anti-Anxiety Agents; Azabicyclo Compounds; Benzodiazep | 2008 |
Insomnia in the elderly.
Topics: Aged; Cognitive Behavioral Therapy; Flurazepam; Humans; Risk Factors; Sleep; Sleep Initiation and Ma | 2007 |
Insomnia. Diagnosis and management.
Topics: Anti-Anxiety Agents; Azabicyclo Compounds; Cognitive Behavioral Therapy; Humans; Hypnotics and Sedat | 2002 |
Clinical trials of hypnotics.
Topics: Anti-Anxiety Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Flurazepam; Half-Li | 1983 |
Sleep laboratory studies of hypnotic drugs: efficacy and withdrawal effects.
Topics: Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety; Dose-Response Relationship, Drug; Fl | 1983 |
Behavioral treatment for chronic insomnia.
Topics: Anti-Anxiety Agents; Behavior Therapy; Chronic Disease; Cognitive Behavioral Therapy; Combined Modal | 2002 |
A review of the safety profiles of benzodiazepine hypnotics.
Topics: Aged; Anti-Anxiety Agents; Benzodiazepines; Central Nervous System; Flurazepam; Half-Life; Humans; H | 1991 |
Rebound insomnia: a critical review.
Topics: Anti-Anxiety Agents; Flurazepam; Humans; Sleep Initiation and Maintenance Disorders; Sleep Stages; S | 1989 |
52 trials available for temazepam and Chronic Insomnia
| Article | Year |
|---|---|
Long-term persistence of withdrawal of temazepam, zopiclone, and zolpidem in older adults: a 3-year follow-up study.
Topics: Aged; Azabicyclo Compounds; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypnotics and Se | 2018 |
Withdrawal from long-term use of zopiclone, zolpidem and temazepam may improve perceived sleep and quality of life in older adults with primary insomnia.
Topics: Aged; Aged, 80 and over; Azabicyclo Compounds; Double-Blind Method; Female; Humans; Hypnotics and Se | 2019 |
Handgrip strength and balance in older adults following withdrawal from long-term use of temazepam, zopiclone or zolpidem as hypnotics.
Topics: Aged; Aged, 80 and over; Azabicyclo Compounds; Female; Follow-Up Studies; Hand Strength; Humans; Hyp | 2014 |
Adverse effects of temazepam in older adults with chronic insomnia.
Topics: Aged; Aged, 80 and over; Anti-Anxiety Agents; Cognitive Behavioral Therapy; Combined Modality Therap | 2003 |
Effects of after-midnight intake of zolpidem and temazepam on driving ability in women with non-organic insomnia.
Topics: Arousal; Automobile Driving; Circadian Rhythm; Cross-Over Studies; Double-Blind Method; Humans; Hypn | 2003 |
Evaluation of actigraphy and automated telephoned questionnaires to assess hypnotic effects in insomnia.
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Cross-Over Studies; Double-Blind Method; Humans; Middl | 2004 |
Comparison of temazepam 7.5 mg with temazepam 15 mg for the treatment of transient insomnia.
Topics: Adult; Aged; Cognition; Double-Blind Method; Female; Humans; Male; Middle Aged; Polysomnography; Psy | 2004 |
Zolpidem is not superior to temazepam with respect to rebound insomnia: a controlled study.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Double-Blind Method; Drug Tolerance; Female; Humans; Hypnoti | 2004 |
[Signopam treatment of insomnia in patients with somatic pathology].
Topics: Adolescent; Adult; Female; GABA Modulators; Humans; Male; Middle Aged; Sleep Initiation and Maintena | 2004 |
Effects of 2-week treatment with temazepam and diphenhydramine in elderly insomniacs: a randomized, placebo-controlled trial.
Topics: Aged; Aged, 80 and over; Cross-Over Studies; Diphenhydramine; Dizziness; Dose-Response Relationship, | 2008 |
Efficacy and side effects of lorazepam, oxazepam, and temazepam as sleeping aids in psychogeriatric inpatients.
Topics: Aged; Anti-Anxiety Agents; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Lorazepam; | 1980 |
Double-blind evaluation of temazepam, flurazepam, and placebo in geriatric insomniacs.
Topics: Aged; Anti-Anxiety Agents; Clinical Trials as Topic; Double-Blind Method; Female; Flurazepam; Humans | 1982 |
Treatment of insomnia with temazepam: double-blind, placebo-controlled evaluation.
Topics: Adult; Anti-Anxiety Agents; Clinical Trials as Topic; Double-Blind Method; Electroencephalography; F | 1982 |
Model insomnia by methylphenidate and caffeine and use in the evaluation of temazepam.
Topics: Adult; Anti-Anxiety Agents; Caffeine; Drug Evaluation; Electroencephalography; Electrooculography; H | 1982 |
A comparison of chlormezanone and temazepam in sleep disturbance.
Topics: Adult; Anti-Anxiety Agents; Chlormezanone; Female; Humans; Male; Sleep Initiation and Maintenance Di | 1982 |
Clinical trials of hypnotics.
Topics: Anti-Anxiety Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Flurazepam; Half-Li | 1983 |
A comparison of the hypnotic activity of loprazolam, temazepam and placebo in general practice.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Clinical Trials as Topic | 1984 |
Psycho-social stress, insomnia and temazepam: a sleep laboratory evaluation in a "general practice" sample.
Topics: Adult; Anti-Anxiety Agents; Double-Blind Method; Electroencephalography; Female; Humans; Sleep Initi | 1984 |
Temazepam's efficacy in patients with sleep onset insomnia.
Topics: Adult; Anti-Anxiety Agents; Clinical Trials as Topic; Double-Blind Method; Electroencephalography; E | 1984 |
Flurazepam and temazepam in the treatment of insomnia in a general hospital population.
Topics: Adult; Aged; Anti-Anxiety Agents; Clinical Trials as Topic; Double-Blind Method; Female; Flurazepam; | 1984 |
A comparison of temazepam and flurazepam in terms of sleep quality and residual changes in performance.
Topics: Adult; Anti-Anxiety Agents; Attention; Cognition; Discrimination Learning; Female; Flicker Fusion; F | 1984 |
Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial.
Topics: Aged; Analysis of Variance; Anti-Anxiety Agents; Behavior Therapy; Chronic Disease; Cognitive Behavi | 1999 |
A pharmacodynamic Markov mixed-effects model for the effect of temazepam on sleep.
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Cross-Over Studies; Female; Humans; Male; Markov Chain | 2000 |
Are changes in beliefs and attitudes about sleep related to sleep improvements in the treatment of insomnia?
Topics: Anti-Anxiety Agents; Attitude; Cognitive Behavioral Therapy; Female; Follow-Up Studies; Humans; Inte | 2002 |
Euhypnos Forte (temazepam) in insomniac patients: a clinical trial in general practice.
Topics: Anti-Anxiety Agents; Capsules; Clinical Trials as Topic; Family Practice; Humans; Patient Dropouts; | 1979 |
Euhypnos Forte (temazepam) for resistant insomnia: a clinical trial.
Topics: Anti-Anxiety Agents; Anxiety; Capsules; Clinical Trials as Topic; Depression; Humans; Hypnotics and | 1979 |
Hypnotic efficacy of temazepam: a long-term sleep laboratory evaluation.
Topics: Adult; Anti-Anxiety Agents; Clinical Trials as Topic; Drug Tolerance; Electroencephalography; Humans | 1979 |
Double-blind evaluation of the safety and hypnotic efficacy of temazepam in insomniac outpatients.
Topics: Anti-Anxiety Agents; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Placebos; | 1979 |
Double-blind evaluation of the efficacy and safety of temazepam in outpatients with insomnia.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Clinical Trials as Topic; Double-Blind Method; Female; Human | 1979 |
A double-blind comparison of the effects of temazepam and triazolam on residual, daytime performance in elderly insomniacs.
Topics: Aged; Cognition; Double-Blind Method; Female; Geriatric Assessment; Humans; Male; Neuropsychological | 1992 |
Next-day memory impairment with triazolam use.
Topics: Activities of Daily Living; Adolescent; Adult; Amnesia, Retrograde; Capsules; Double-Blind Method; D | 1991 |
A single-dose study of the pharmacodynamic effects of chlormethiazole, temazepam and placebo in elderly parkinsonian patients.
Topics: Aged; Benserazide; Carbidopa; Chlormethiazole; Double-Blind Method; Drug Therapy, Combination; Femal | 1991 |
Rebound insomnia after only brief and intermittent use of rapidly eliminated benzodiazepines.
Topics: Adult; Female; Humans; Male; Middle Aged; Monitoring, Physiologic; Random Allocation; Sleep Initiati | 1991 |
A double-blind placebo-controlled trial of zopiclone 7.5 mg and temazepam 20 mg in insomnia.
Topics: Adult; Azabicyclo Compounds; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Malaysia; | 1990 |
Dose effects of temazepam in transient insomnia.
Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Electroencephalography; Electromyograp | 1990 |
Temazepam withdrawal in elderly hospitalized patients: a double blind randomised trial comparing abrupt versus gradual withdrawal.
Topics: Aged; Aged, 80 and over; Anti-Anxiety Agents; Confusion; Double-Blind Method; Female; Humans; Inpati | 1989 |
Zopiclone: a non-benzodiazepine hypnotic. Controlled comparison to temazepam in insomnia.
Topics: Adult; Aged; Anti-Anxiety Agents; Azabicyclo Compounds; Clinical Trials as Topic; Double-Blind Metho | 1985 |
The effects of midazolam and temazepam on sleep and performance when administered in the middle of the night.
Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Female; Humans; Hypnotics and Sedatives; Male; Midazola | 1985 |
Quazepam and temazepam: effects of short- and intermediate-term use and withdrawal.
Topics: Adult; Aged; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Drug Evaluation; Half-L | 1986 |
A double-blind comparison of chlormethiazole and temazepam in elderly patients with sleep disturbances.
Topics: Aged; Anti-Anxiety Agents; Attention; Chlormethiazole; Clinical Trials as Topic; Double-Blind Method | 1986 |
Dose effects of temazepam tablets on sleep.
Topics: Adult; Anti-Anxiety Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind | 1986 |
Nocturnal myoclonus: treatment efficacy of clonazepam and temazepam.
Topics: Adult; Anti-Anxiety Agents; Clinical Trials as Topic; Clonazepam; Female; Humans; Male; Middle Aged; | 1986 |
Saccadic eye movements as a measure of residual effects: temazepam compared with other hypnotics.
Topics: Adult; Anti-Anxiety Agents; Clinical Trials as Topic; Double-Blind Method; Eye Movements; Female; Fl | 1986 |
Aspects of driving after hypnotic therapy with particular reference to temazepam.
Topics: Anti-Anxiety Agents; Arousal; Attention; Automobile Driving; Female; Flunitrazepam; Humans; Male; Ps | 1986 |
Insomnia in general practice: the role of temazepam and a comparison with zopiclone.
Topics: Anti-Anxiety Agents; Arousal; Azabicyclo Compounds; Clinical Trials as Topic; Double-Blind Method; H | 1986 |
Psychopharmacological aspects of idiopathic and transient insomnia.
Topics: Adult; Anti-Anxiety Agents; Arousal; Attention; Clinical Trials as Topic; Double-Blind Method; Human | 1986 |
Subjective effects during administration and on discontinuation of zopiclone and temazepam in normal subjects.
Topics: Adult; Anti-Anxiety Agents; Anxiety; Arousal; Azabicyclo Compounds; Female; Humans; Hypnotics and Se | 1987 |
Evaluation of temazepam and diphenhydramine as hypnotics in a nursing-home population.
Topics: Aged; Anti-Anxiety Agents; Diphenhydramine; Drug Evaluation; Female; Florida; Humans; Hypnotics and | 1987 |
Efficacy without tolerance or rebound insomnia for midazolam and temazepam after use for one to three months.
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Clinical Trials as Topic; Double-Blind Method; Drug To | 1987 |
Comparative amnestic effects of benzodiazepine hypnotic agents.
Topics: Adult; Amnesia; Anti-Anxiety Agents; Dose-Response Relationship, Drug; Humans; Memory, Short-Term; M | 1988 |
Altitude insomnia: studies during an expedition to the Himalayas.
Topics: Acetazolamide; Adult; Altitude Sickness; Anti-Anxiety Agents; Dose-Response Relationship, Drug; Elec | 1988 |
Hypnotics and actual driving performance.
Topics: Adult; Attention; Automobile Driving; Clinical Trials as Topic; Dose-Response Relationship, Drug; Do | 1986 |
31 other studies available for temazepam and Chronic Insomnia
| Article | Year |
|---|---|
Effect of withdrawal from long-term use of temazepam, zopiclone or zolpidem as hypnotic agents on cognition in older adults.
Topics: Aged; Azabicyclo Compounds; Cognition; Female; Follow-Up Studies; Humans; Hypnotics and Sedatives; M | 2014 |
Effect of withdrawal from long-term use of temazepam, zopiclone or zolpidem as hypnotic agents on cognition in older adults.
Topics: Aged; Azabicyclo Compounds; Cognition; Female; Follow-Up Studies; Humans; Hypnotics and Sedatives; M | 2014 |
Effect of withdrawal from long-term use of temazepam, zopiclone or zolpidem as hypnotic agents on cognition in older adults.
Topics: Aged; Azabicyclo Compounds; Cognition; Female; Follow-Up Studies; Humans; Hypnotics and Sedatives; M | 2014 |
Effect of withdrawal from long-term use of temazepam, zopiclone or zolpidem as hypnotic agents on cognition in older adults.
Topics: Aged; Azabicyclo Compounds; Cognition; Female; Follow-Up Studies; Humans; Hypnotics and Sedatives; M | 2014 |
Understanding women's sleep management: beyond medicalization-healthicization?
Topics: Adult; Aged; Anti-Anxiety Agents; Family Practice; Female; Focus Groups; Humans; Hypnotics and Sedat | 2003 |
Effects of temazepam 7.5 mg and temazepam 15 mg on sleep maintenance and sleep architecture in a model of transient insomnia.
Topics: Adult; Aged; Anti-Anxiety Agents; Biomarkers; Double-Blind Method; Female; Humans; Male; Middle Aged | 2005 |
Visual hallucination and temazepam: an unusual case.
Topics: Aged, 80 and over; Anti-Anxiety Agents; Hallucinations; Humans; Male; Sleep Initiation and Maintenan | 2006 |
Euhypnos forte, high dose temazepam for resistant insomnia: post-marketing surveillance in 10,057 patients unresponsive to conventional hypnotic dosage.
Topics: Anti-Anxiety Agents; Dose-Response Relationship, Drug; Humans; Sleep Initiation and Maintenance Diso | 1980 |
Drugs & dosages: Restoril.
Topics: Anti-Anxiety Agents; Humans; Sleep Initiation and Maintenance Disorders; Temazepam | 1981 |
Temazepam (Restoril) - another benzodiazepine for insomnia.
Topics: Anti-Anxiety Agents; Female; Humans; Male; Sleep Initiation and Maintenance Disorders; Temazepam | 1982 |
[Effects of temazepam on experimental insomnia induced by methylphenidate in man].
Topics: Adolescent; Adult; Anti-Anxiety Agents; Double-Blind Method; Habituation, Psychophysiologic; Humans; | 1982 |
[Evening television and sleep. Polysomnographic, psychometric and psychopharmacologic studies in sleep disordered patients (II)].
Topics: Anti-Anxiety Agents; Dose-Response Relationship, Drug; Humans; Sleep Initiation and Maintenance Diso | 1983 |
Withdrawal after substitution of a short-acting for a long-acting benzodiazepine.
Topics: Anti-Anxiety Agents; Anxiety; Chronic Disease; Delayed-Action Preparations; Diazepam; Flurazepam; Ha | 1983 |
Insomnia and short-acting benzodiazepine hypnotics.
Topics: Benzodiazepines; Chemical Phenomena; Chemistry; Humans; Hypnotics and Sedatives; Kinetics; Sleep; Sl | 1983 |
Long-term monitoring during sleep--a high-speed automatic processing system for human all-night sleep scoring and statistical data analysis.
Topics: Autoanalysis; Caffeine; Electroencephalography; Electromyography; Humans; Minicomputers; Monitoring, | 1982 |
Temazepam 7.5 mg: effects on sleep in elderly insomniacs.
Topics: Aged; Anxiety; Chronic Disease; Electroencephalography; Electrooculography; Female; Humans; Male; Sl | 1994 |
Management of insomnia in office-based practice. National prevalence and therapeutic patterns.
Topics: Adolescent; Adult; Aged; Data Collection; Female; Flurazepam; Humans; Male; Medicine; Middle Aged; P | 1993 |
Prescribing practice and policy for hypnotics: a model of pharmacy audit.
Topics: Aged; Drug Utilization; England; Female; Geriatric Assessment; Humans; Hypnotics and Sedatives; Male | 1996 |
Pharmacodynamics of temazepam in primary insomnia: assessment of the value of quantitative electroencephalography and saccadic eye movements in predicting improvement of sleep.
Topics: Adult; Aged; Anti-Anxiety Agents; Electroencephalography; Female; Humans; Male; Middle Aged; Polysom | 1997 |
Pilot evaluation of hypnotic medication during acute traumatic stress response.
Topics: Acute Disease; Adolescent; Adult; Anti-Anxiety Agents; Arousal; Combined Modality Therapy; Crisis In | 1998 |
Behaviour therapy for chronic insomnia.
Topics: Anti-Anxiety Agents; Behavior Therapy; Chronic Disease; Clinical Trials as Topic; Humans; Sleep Init | 2001 |
Use of night-time benzodiazepines in an elderly inpatient population.
Topics: Aged; Aged, 80 and over; Aging; Anti-Anxiety Agents; Female; Geriatrics; Health Care Surveys; Hospit | 2002 |
Euhypnos Forte (temazepam) for resistant insomnia: post-marketing surveillance, an interim report.
Topics: Administration, Oral; Anti-Anxiety Agents; Capsules; Drug Evaluation; Humans; Sleep Initiation and M | 1979 |
Hypnotics today.
Topics: Aged; Anti-Anxiety Agents; Diazepam; Electroencephalography; Humans; Sleep; Sleep Initiation and Mai | 1979 |
Clinical uses and advantages of low doses of benzodiazepine hypnotics.
Topics: Adult; Aged; Amnesia; Benzodiazepines; Dose-Response Relationship, Drug; Drug Administration Schedul | 1992 |
Avoiding the blanket approach to insomnia. Targeted therapy for specific causes.
Topics: Anti-Anxiety Agents; Benzodiazepines; Chronic Disease; Diagnosis, Differential; Estazolam; Flurazepa | 1991 |
The beneficial and adverse effects of hypnotics.
Topics: Adolescent; Adult; Aged; Attitude to Health; Benzodiazepines; Data Collection; Drug Prescriptions; E | 1991 |
Putting benzodiazepine hypnotics into proper therapeutic perspective.
Topics: Anti-Anxiety Agents; Flurazepam; Humans; Sleep Initiation and Maintenance Disorders; Temazepam; Tria | 1985 |
Agitation observed during treatment with newer hypnotic drugs.
Topics: Adult; Aged; Akathisia, Drug-Induced; Anger; Anti-Anxiety Agents; Female; Half-Life; Hostility; Huma | 1985 |
Tranquilizers and sedative/hypnotics: appropriate use in the elderly.
Topics: Aged; Alprazolam; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Half-Life; Humans; Hypnotics and Se | 1986 |
The use of benzodiazepines with particular reference to the elderly.
Topics: Aged; Anti-Anxiety Agents; Anxiety; Chlordiazepoxide; Diazepam; Humans; Infusions, Parenteral; Kinet | 1986 |
Pharmacokinetics of temazepam compared with other benzodiazepine hypnotics--some clinical consequences.
Topics: Anti-Anxiety Agents; Drug Administration Schedule; Humans; Kinetics; Sleep Initiation and Maintenanc | 1986 |
Hypnotics and transient insomnia.
Topics: Altitude; Anti-Anxiety Agents; Arousal; Attention; Humans; Sleep Initiation and Maintenance Disorder | 1986 |
Update on hypnotics for insomnia in clinical practice: I. Hypnotics.
Topics: Adult; Humans; Hypnotics and Sedatives; Sleep Initiation and Maintenance Disorders; Temazepam; Triaz | 1986 |